Mohamed Bashir Selected Research

Fittydent

2/2021

Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamed Bashir Research Topics

Disease

5	Kidney Calculi (Kidney Stone) 01/2020 - 03/2017
5	Hyperoxaluria (Oxaluria) 01/2020 - 03/2017
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Obesity 01/2019 - 01/2018
1	Diabetes Mellitus 02/2021
1	Hypoglycemia (Reactive Hypoglycemia) 02/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2020
1	Infections 12/2020
1	Opportunistic Infections (Opportunistic Infection) 12/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2018
1	Primary hyperoxaluria type 1 03/2017
1	Myocardial Infarction 04/2013
1	Hypertension (High Blood Pressure) 04/2013

Drug/Important Bio-Agent (IBA)

5	OxalatesIBA 01/2020 - 03/2017
4	Calcium OxalateIBA 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 04/2013
2	CytokinesIBA 01/2019 - 01/2018
1	FittydentIBA 02/2021
1	Insulin (Novolin)FDA Link 02/2021
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 11/2018
1	AnionsIBA 11/2018
1	CholesterolIBA 04/2013
1	Triglycerides (Triacylglycerol)IBA 04/2013
1	CreatinineIBA 04/2013

Therapy/Procedure

3	Therapeutics 02/2021 - 03/2017
1	Art Therapy 12/2020
1	Rectal Administration 03/2017